SCHEMBL4873475

SCHEMBL4873475

COc1cccc(C2(C(=O)NS(=O)(=O)N(C)c3ccccc3)CCN(c3ncccn3)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 1/20 0.43
KDM4E B2RXH2 4/20 0.42
KMT2A Q03164 3/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
OPRD1 P41143 4/20 0.42
KCNH2 Q12809 1/20 0.42
CYP3A4 P08684 3/20 0.40
USP2 O75604 2/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP2C9 P11712 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876755 0.87 OPRD1 (0.44) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4876692 0.85 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4868393 0.84 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4876628 0.83 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4876648 0.83 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4878695 0.82 OPRD1 (0.49) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4872054 0.81 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL5487731 0.81 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4877181 0.80 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EKMT2ATP53
SCHEMBL4873649 0.80 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 ALDH1A1 2899/4885HPGD 3005/4885KDM4E 768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.